A well-established method for breast augmentation is the insertion of silicone gel implants. Only high-quality implants from certified companies that offer a warranty on the implants are used.
A wide range of different implant shapes and sizes are available: essentially anatomically shaped (teardrop) and round implants in various widths, heights, and projections. There are micro-textured, rough, smooth, and PU-coated surfaces available. Additionally, there are B-Lite® implants that are about 30% lighter.
The implants are placed under the major pectoral muscle (which covers about the upper half of the implant), completely under the muscle, or under the breast tissue (i.e., on the muscle), taking into account the breast shape and size and the risk of capsule fibrosis.
The access routes and the resulting scar locations include the inframammary fold (under the breast), the armpit, and the areola border. Scars in these areas, when using precise suturing techniques, are generally inconspicuous, delicate, and pale. The length of the scar depends, among other things, on the size of the implant.
Scar path inframammary fold
Scar around half areola
Scar in armpit
The recommendation for implant shape, position, and scar location depends on the patient’s body, breast shape, size, and personal preferences, and can only be made after a detailed consultation and thorough examination. Various anatomical parameters are measured, and based on these, the optimal implant shape and size are calculated. By inserting different trial implants into a special bra, the surgical result can be simulated, helping the patient choose the implant size. Expectations, success probability, potential complications, necessary preparatory examinations, and post-operative care are also discussed.
The goal is an attractively shaped, naturally appearing, full breast in harmonious coordination with the overall appearance of the woman.
Since breast augmentation with implants involves the long-term implantation of a foreign body, women must be clearly informed about risks such as capsule fibrosis and breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) during the consultation. The chosen surgical method should minimize these risks as much as possible.
Since 2024, Germany has introduced a mandatory breast implant registry, which will provide more security and transparency regarding breast implants for both patients and surgeons.